|
STK17A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.741600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.131400E-01 |
| Normal-vs-Stage2 |
8.311800E-01 |
| Normal-vs-Stage3 |
5.735600E-01 |
| Normal-vs-Stage4 |
1.209350E-01 |
| Stage1-vs-Stage2 |
6.524600E-01 |
| Stage1-vs-Stage3 |
3.631800E-01 |
| Stage1-vs-Stage4 |
2.923500E-02 |
| Stage2-vs-Stage3 |
7.530200E-01 |
| Stage2-vs-Stage4 |
2.216000E-01 |
| Stage3-vs-Stage4 |
3.395600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.088000E-01 |
| Normal-vs-AfricanAmerican |
2.051600E-02 |
| Normal-vs-Asian |
9.530800E-01 |
| Caucasian-vs-AfricanAmerican |
5.53269999999939E-05 |
| Caucasian-vs-Asian |
7.705000E-01 |
| AfricanAmerican-vs-Asian |
2.360400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.426000E-01 |
| Normal-vs-Female |
5.157400E-01 |
| Male-vs-Female |
2.855700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.570000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.405800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.610800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.378600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.049800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.378800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.618030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.484400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.566400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.261900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.681900E-03 |
| Normal-vs-Grade 2 |
8.802200E-01 |
| Normal-vs-Grade 3 |
9.567800E-01 |
| Normal-vs-Grade 4 |
4.066000E-02 |
| Grade 1-vs-Grade 2 |
1.498040E-03 |
| Grade 1-vs-Grade 3 |
7.197100E-04 |
| Grade 1-vs-Grade 4 |
2.76249999997535E-06 |
| Grade 2-vs-Grade 3 |
8.891000E-01 |
| Grade 2-vs-Grade 4 |
1.995600E-02 |
| Grade 3-vs-Grade 4 |
1.317790E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.479000E-03 |
| Normal-vs-ccB subtype |
1.036250E-03 |
| ccA subtype-vs-ccB subtype |
1.96830329812769E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.725400E-01 |
| Normal-vs-N1 |
1.498800E-01 |
| N0-vs-N1 |
2.192400E-01 |
|
|
